Angiolab, Inc. (XKON:251280)
1,850.00
-315.00 (-14.55%)
At close: Nov 12, 2026
| Market Cap | 6.46B -55.9% |
| Revenue (ttm) | 702.62M -20.0% |
| Net Income | -1.19B |
| EPS | -1,356.00 |
| Shares Out | 3.49M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,134 |
| Open | 2,200.00 |
| Previous Close | 2,165.00 |
| Day's Range | 1,845.00 - 2,200.00 |
| 52-Week Range | 1,523.00 - 4,300.00 |
| Beta | -0.13 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |